Open AccessMathematical modeling as the method of choice of the pharmacoeconomically reasonable regimen of the combined therapy of type 2 diabetes
Author(s) -
Т. І. Івко,
Т. А. Germanyuk
Publication year - 2015
Publication title -
klìnìčna farmacìâ
Language(s) - English
Resource type - Journals
eISSN - 2518-1572
pISSN - 1562-725X
DOI - 10.24959/cphj.15.1354
Subject(s) - gliclazide , glimepiride , metformin , glibenclamide , medicine , regimen , diabetes mellitus , type 2 diabetes , pharmacoeconomics , type 2 diabetes mellitus , pharmacology , urology , endocrinology , intensive care medicine